12 Institutional Investors Exited Positions In Tandem Diabetes Care, Inc. (TNDM)

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) went up to recover about 1623.83% since recording its record low price of $2.14. The stock experienced 6.28% jump, arriving at $36.89 on 01/07/2019. During the day, the stock price traveled from $35.1 to $37.7. This company shares are 39.22% off its target price of $51.36 and the current market capitalization stands at $2.07B. The recent change has given its price a 5.74% lead over SMA 50 and -29.8% deficit over its 52-week high. The stock witnessed 4.65% gains, 5.31% gains and 60.04% gains for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found TNDM’s volatility during a week at 7.74% and during a month it has been found around 7.97%.

Tandem Diabetes Care, Inc. (TNDM) Top Holders

Institutional investors currently hold around $1.43 billion or 77.7% in TNDM stock. Look at its top three institutional owners. Blackrock Inc. owns $135.69 million in Tandem Diabetes Care, Inc., which represents roughly 6.56% of the company’s market cap and approximately 9.48% of the institutional ownership. Similar statistics are true for the second largest owner, Vanguard Group Inc, which owns 3,792,662 shares of the stock are valued at $131.64 million. The third largest holder is Fred Alger Management Inc, which currently holds $117.02 million worth of this stock and that ownership represents nearly 5.65% of its market capitalization.

Tandem Diabetes Care, Inc. 13F Filings

At the end of September reporting period, 137 institutional holders increased their position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM) by some 18,748,758 shares, 50 decreased positions by 10,896,022 and 8 held positions by 11,580,246. That puts total institutional holdings at 41,225,026 shares, according to SEC filings. The stock grabbed 80 new institutional investments totaling 8,715,360 shares while 12 institutional investors sold out their entire positions totaling 1,220,338 shares.

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Insider Trades

Multiple company employees have indulged in significant insider trading. Tandem Diabetes Care, Inc. disclosed in a document filed with the US Securities and Exchange Commission (SEC) that EVP, CHIEF OPERATING OFFICER Sheridan John F has sold 20,788 shares of Tandem Diabetes Care, Inc. (TNDM) in trading session dated Jan. 02, 2019. These shares are worth $743,379 and were traded at $35.76 each. The SEC filing shows that Hansen Brian B performed a sale of 25,000 shares. The EVP & CHIEF COMMERCIAL OFFICER disposed these shares by way of transaction on Dec. 12, 2018. The company’s shares were given away at $37.75 per share worth to an income of some $943,750 on account of Hansen Brian B.

EVP, GEN. COUNSEL & SECRETARY, Berger David B, sold 11,493 common shares of Tandem Diabetes Care, Inc. (TNDM) in the open market. In a transaction dated Dec. 06, 2018, the shares were put up for sale at an average price of $34.54, raking in a sum of $396,968. After this sale, 1,965 common shares of TNDM are directly owned by the insider, with total stake valued at $72,489.

In the transaction dated Dec. 06, 2018, the great number of shares disposed came courtesy the EVP, GEN. COUNSEL & SECRETARY; Berger David B disposed a total of 11,493 shares at an average price of $34.54, amounting to approximately $396,968. The insider now directly owns 1,965 shares worth $72,489.

Tandem Diabetes Care, Inc. (TNDM) Analyst Guide

Several analysts have released their opinion on Tandem Diabetes Care, Inc. (NASDAQ:TNDM), with 3 analysts believing it is a strong buy. Whereas 2 of them predict the stock is a hold. Also, there are 5 buy, 0 sell and 0 strong sell ratings, collectively assigning a 1.9 average brokerage recommendation.